Famotidine 10mg Oral Suspension from Canada
Famotidine 10mg oral suspension is a liquid formulation for pediatric or dysphagic patients treating acid-related digestive disorders. Put up in measured doses for retail sale with famotidine as active, it is under HTS 3004.90.92.54.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide stability data for liquid forms to confirm shelf-life compliance during import
• Label with shake-well instructions and concentration per mL for accurate dosing verification
• Separate from unmixed syrup bases, as dissolution in water still counts as unmixed per Chapter notes